Kelly Keen transitioned into biotechnology, drug development, CMC, SCM and pharmatechnical business project & portfolio management at Roche & Genentech. She founded kellykeen.com this year in response to clients needing consulting for Project, Program & Portfolio set-ups. She finished serving on the ISPE, International Society of Pharmaceutical Engineers, Board of Directors in 2019 and chaired a course at UC Berkeley Bioengineering from 2006-16.
Over her career, her clients include Novartis, Exelixis, as well as many high-tech companies in the SF Bay Area. Her focus is on bringing culture and creativity into the workplace and is helping European and Asian firms operate more Agile as the Bay Area dotcom culture where she began her career.
She obtained her MBA while living in Singapore from the Edward S. Ageno School of Business and is currently enrolled in executive certificates at INSEAD and MIT. Her Master´s degree in Architectural Engineering is from the University of Illinois and l`École Nationale Supérieure d’Architecture in Versailles, France.